Be a Smart Investor
Wednesday, November 15, 2017
Shanghai Pharma buys US Cardinal Health's China business for $557 million
Shanghai Pharmaceuticals has agreed to buy Cardinal Health's China drug distribution business for $557 million.
from Mergers and Acquisitions http://ift.tt/2zFCNwB
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment